OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
September 01, 2009
The authors describe the various available technologies used in orally disintegrating tablets.
Why correctly calibrating a drug with its packaging is the key to success.
August 28, 2009
The Czech Republic will no longer purchase the H1N1 flu vaccine from Baxter International.
Scientists have modified a tobacco plant to produce a vaccine for norovirus, the viral infection sometimes referred to as the "cruise ship virus".
August 27, 2009
Scientists have modified a tobacco plant to produce a vaccine for norovirus, the viral infection sometimes called the "cruise ship virus."
August 21, 2009
NIR Prediction of Solid Dosage Form Dissolution Profiles - Foss Whitepaper
Extending Calibrations for Near-Infrared Assay of Tablets Using Synthetic Modeling and Variance from Placebos - Foss Whitepaper
August 19, 2009
Cooling water is a critical component in the research and development, bulk manufacturing, and packaging of pharmaceuticals.
August 13, 2009
Baxter International (Deerfield, IL), sanofi aventis (Paris), and Novartis (Basel, Switzerland) provided updates last week of their production and regulatory activities relating to preparedness in supplying the A(H1N1) pandemic influenza vaccine. Novartis also outlined its activities for providing seasonal flu vaccines.
August 02, 2009
The authors prepared granules containing cinnarizine using polyethylene glycol 6000 as a melting binder and lactose monohydrate as hydrophilic filler. The effects of binder concentration and size were studied.